ArticleJournal of hepatocellular carcinoma2025

The Prognostic Value of Peripheral Blood Inflammatory Markers in Hepatocellular Carcinoma Treated with Lenvatinib Combined with PD-1 Inhibitors.

Yujing Xin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.